WO2021218171A1 - 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 - Google Patents
一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 Download PDFInfo
- Publication number
- WO2021218171A1 WO2021218171A1 PCT/CN2020/135515 CN2020135515W WO2021218171A1 WO 2021218171 A1 WO2021218171 A1 WO 2021218171A1 CN 2020135515 W CN2020135515 W CN 2020135515W WO 2021218171 A1 WO2021218171 A1 WO 2021218171A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- application
- preparation
- mannanase
- gum
- partially hydrolyzed
- Prior art date
Links
- 108010055059 beta-Mannosidase Proteins 0.000 title claims abstract description 115
- 229920000057 Mannan Polymers 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 82
- 230000000694 effects Effects 0.000 claims abstract description 69
- 235000013618 yogurt Nutrition 0.000 claims abstract description 66
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 43
- 229920001938 Vegetable gum Polymers 0.000 claims abstract description 24
- 102100035029 Ataxin-1 Human genes 0.000 claims abstract description 17
- 101000873082 Homo sapiens Ataxin-1 Proteins 0.000 claims abstract description 17
- 238000012258 culturing Methods 0.000 claims abstract description 3
- 241001247414 Couma Species 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 44
- LUEWUZLMQUOBSB-GFVSVBBRSA-N mannan Chemical class O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-GFVSVBBRSA-N 0.000 claims description 27
- 235000013406 prebiotics Nutrition 0.000 claims description 24
- 239000001884 Cassia gum Substances 0.000 claims description 21
- 235000019318 cassia gum Nutrition 0.000 claims description 21
- 229920001542 oligosaccharide Polymers 0.000 claims description 21
- 108020004414 DNA Proteins 0.000 claims description 20
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 18
- 229920000161 Locust bean gum Polymers 0.000 claims description 16
- 239000000711 locust bean gum Substances 0.000 claims description 16
- 235000010420 locust bean gum Nutrition 0.000 claims description 16
- 229940072645 coumadin Drugs 0.000 claims description 15
- 239000013598 vector Substances 0.000 claims description 15
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 claims description 15
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 14
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 14
- 229920002752 Konjac Polymers 0.000 claims description 14
- 239000000252 konjac Substances 0.000 claims description 14
- 235000010485 konjac Nutrition 0.000 claims description 14
- -1 mannose oligosaccharides Chemical class 0.000 claims description 13
- 235000013312 flour Nutrition 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 11
- 102000053602 DNA Human genes 0.000 claims description 9
- 230000015556 catabolic process Effects 0.000 claims description 9
- 238000006731 degradation reaction Methods 0.000 claims description 9
- 230000000593 degrading effect Effects 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- 241000233866 Fungi Species 0.000 claims description 7
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 6
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 6
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 4
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 3
- 102000037865 fusion proteins Human genes 0.000 claims description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 2
- 238000012217 deletion Methods 0.000 claims description 2
- 230000037430 deletion Effects 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 abstract description 74
- 108090000790 Enzymes Proteins 0.000 abstract description 74
- 238000006116 polymerization reaction Methods 0.000 abstract description 14
- 235000013305 food Nutrition 0.000 abstract description 9
- 239000000047 product Substances 0.000 description 56
- 239000000243 solution Substances 0.000 description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 238000000855 fermentation Methods 0.000 description 27
- 230000004151 fermentation Effects 0.000 description 27
- 230000007062 hydrolysis Effects 0.000 description 24
- 238000006460 hydrolysis reaction Methods 0.000 description 24
- 241000894006 Bacteria Species 0.000 description 22
- 239000000872 buffer Substances 0.000 description 17
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 16
- 108010010803 Gelatin Proteins 0.000 description 15
- 239000008273 gelatin Substances 0.000 description 15
- 229920000159 gelatin Polymers 0.000 description 15
- 235000019322 gelatine Nutrition 0.000 description 15
- 235000011852 gelatine desserts Nutrition 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 12
- 241000186660 Lactobacillus Species 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 description 7
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 7
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 7
- LHAOFBCHXGZGOR-NAVBLJQLSA-N alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1 LHAOFBCHXGZGOR-NAVBLJQLSA-N 0.000 description 7
- LUEWUZLMQUOBSB-MHJOMNRISA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](OC(O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O LUEWUZLMQUOBSB-MHJOMNRISA-N 0.000 description 7
- 239000007979 citrate buffer Substances 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 7
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 6
- YETHWGOYCQLNKG-FHERGOJNSA-N alpha-D-Manp-(1->3)-[alpha-D-Manp-(1->6)]-alpha-D-Manp-(1->2)-alpha-D-Manp-(1->2)-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@H]1O[C@@H]1[C@@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YETHWGOYCQLNKG-FHERGOJNSA-N 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- OCIBBXPLUVYKCH-KKQGKRJZSA-N beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](O[C@@H](O[C@@H]4[C@H](O[C@@H](O[C@@H]5[C@H](OC(O)[C@@H](O)[C@H]5O)CO)[C@@H](O)[C@H]4O)CO)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@@H](O)[C@H]1O OCIBBXPLUVYKCH-KKQGKRJZSA-N 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 238000005227 gel permeation chromatography Methods 0.000 description 6
- 239000000413 hydrolysate Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 229920002907 Guar gum Polymers 0.000 description 5
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 5
- 241001460678 Napo <wasp> Species 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 229960000956 coumarin Drugs 0.000 description 5
- 235000001671 coumarin Nutrition 0.000 description 5
- 239000000665 guar gum Substances 0.000 description 5
- 235000010417 guar gum Nutrition 0.000 description 5
- 229960002154 guar gum Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 4
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 4
- 239000012506 Sephacryl® Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 229920000926 Galactomannan Polymers 0.000 description 3
- 241000235058 Komagataella pastoris Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000022811 deglycosylation Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000013494 PH determination Methods 0.000 description 2
- 101150051118 PTM1 gene Proteins 0.000 description 2
- 108010028230 Trp-Ser- His-Pro-Gln-Phe-Glu-Lys Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000009825 enzymatic declygosylation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 101150061183 AOX1 gene Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000916162 Rhizomucor miehei CAU432 Species 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical compound OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 1
- 150000002704 mannoses Chemical class 0.000 description 1
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/2488—Mannanases
- C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Definitions
- the invention relates to a preparation method of ⁇ -mannanase and its application in the preparation of partially hydrolyzed mannans in the field of biotechnology.
- Mannan is a class of linear polysaccharides connected by mannose with ⁇ -1,4-D-pyranoside bonds. Certain residues of the main chain can also be connected with ⁇ -1,4-glycosidic bonds. Glucose residues are substituted with galactose residues linked by ⁇ -1,6-glycosidic bonds. Mannan is the second major component of hemicellulose, and its content is second only to xylan. It is widely distributed in nature, in the endosperm of legume seeds, some plant gums (such as locust bean gum, couma gum, etc.), Coconut meat and konjac bulbs are rich in mannans (Hsu et al.
- mannans can be divided into linear mannans, galactomannans, glucomannans and galacto-glucomannans (Petkowicz et al. Carbohydrate Polymers, 2001, 44:107-112).
- ⁇ -Mannanase is a key enzyme for the hydrolysis of mannans. It can randomly hydrolyze ⁇ -1,4-glycosidic bonds in the main chain of mannans to generate mannoligosaccharides (Malgas et al. World Journal of Microbiology and Biotechnology, 2015,31:1167-1175).
- ⁇ -mannanase is widely distributed in nature, and ⁇ -mannanase can be isolated and extracted from plants, lower animals and microorganisms, and microorganisms are the main source of ⁇ -mannanase.
- Microbial ⁇ -mannanase has many advantages, such as simple enzyme production conditions, large enzyme production, stable source, convenient extraction, and diverse enzymatic properties. Therefore, ⁇ -mannanase derived from microorganisms is widely used in food, feed and other industries (Srivastava and Kapoor. Biotechnology Advances, 2017, 35:1-19).
- ⁇ -mannanase can be divided into glycoside hydrolase 5, 26, 113 and 134 families (Srivastava and Kapoor. Biotechnology advances, 2017, 35:1-19).
- the vast majority of ⁇ -mannanases belong to the 5 and 26 families of glycoside hydrolases (GH).
- the GH5 family ⁇ -mannanase has been used to prepare partially hydrolyzed mannans, such as the GH5 family ⁇ -mannanase from Arabidopsis thaliana (Wang et al.Planta, 2014, 239:653-665) and Rhizomucor miehei CAU432 It can produce partially hydrolyzed guar gum (Li et al. International Journal of Biological Macromolecules, 2017, 105: 1171-1179).
- the substrate is a galactomannan with more galactose substituents in the side chain
- GH26 family ⁇ -mannanase has more advantages (von Freiesleben et al.
- GH26 family ⁇ -mannanase has been successfully expressed in yeast, but the expression level is low, such as Thermophilic Bacillus subtilis (TBS2) ⁇ -mannanase (ReTMan26) ) Enzyme activity is 5435U/mL (Luo et al. Applied Biochemistry and Biotechnology, 2017, 182:1259-1275) and Aspergillus niger (Aspergillus niger) ⁇ -mannanase expressed in Pichia pastoris enzyme activity is 5069U/mL (Zhao et al. Bioresource Technology, 2011, 102: 7538-7547). Therefore, increasing the expression level of GH26 family ⁇ -mannanase is of great significance to its industrial application.
- partially hydrolyzed mannan As a prebiotic, partially hydrolyzed mannan has the characteristics of low calorie, stable properties, promotes the proliferation of beneficial bacteria in the organism, and regulates metabolic circulation. It can be widely used in the food industry (Mudgil et al. International Journal of Biological Macromolecules, 2018) ,112:207-210; Kapoor et al. Journal of Function Foods,2016,24:207-220). At present, methods such as high temperature degradation, acid-base hydrolysis and enzymatic hydrolysis are mainly used to prepare partially hydrolyzed mannans.
- Enzymatic preparation of partially hydrolyzed mannans has the advantages of easy process control, mild reaction conditions, and few side reactions, and has become the most commonly used method in the preparation of partially hydrolyzed mannans.
- the substrates for preparing partially hydrolyzed mannans are mainly plant gums rich in mannans. Among them, the raw materials commonly used to prepare partially hydrolyzed mannans are konjac flour and guar gum, but the concentration of raw materials used during hydrolysis is low ( ⁇ 5%) (Mao et al.
- Cipheral Patent No. ZL201610808817.0 discloses a method for preparing partially hydrolyzed guar gum by enzymatically hydrolyzing guar gum using mannanase derived from Rhizomucor miehei. The concentration of guar gum used is low, only 5%. .
- cassia gum, couma gum and other plant gums rich in mannan are also good substrates for preparing partially hydrolyzed mannans, but there are few related reports and patents (Daas et al. Carbohydrate Polymers, 2017, 158: 102- 111).
- Chinese Patent No. ZL201410024844.X discloses a method for preparing a thickener of couma gum. The endosperm of couma seeds is enzymatically treated with a biological enzyme solution, which improves the performance of couma gum powder;
- Chinese patent application No. CN201710478917.6 Disclosed is a method for preparing a health food for preventing and treating hyperlipidemia.
- ⁇ -mannanase water to solve plant gums such as gelatin and couma gum and increase the substrate concentration to produce partially hydrolyzed mannans can enrich the prebiotic market in my country and have broad development prospects.
- Yogurt is a food made from fresh milk and fermented by Streptococcus thermophilus and Lactobacillus bulgaricus. Yogurt is delicate and smooth, thick in texture, sweet and sour, and has the advantages of easy digestion and absorption, promoting intestinal peristalsis, regulating the balance of intestinal flora, anti-oxidation and anti-bacterial, and lowering blood pressure (Farvin et al. Food Chemistry, 2010, 123: 1090-1097; Donkor et al. International Dairy Journal, 2007, 17: 1321-1331). Adding prebiotics to yogurt to prepare prebiotic yogurt can improve the physical and chemical properties of yogurt and increase the functional activity of yogurt, which has attracted wide attention (Cruz et al.
- Chinese Patent Application No. CN201811327958.6 discloses a method for making brown oligosaccharide yogurt, adding 1-3g/L xylo-oligosaccharides, 15-22g/L fructo-oligosaccharides, 18-26g/L low The polyisomaltose is made into prebiotic yogurt, which is rich in nutrients, is beneficial to human health, and meets the consumption requirements of modern people for yogurt.
- CN201910276659.2 discloses a method for preparing prebiotic yogurt, adding 0.02%-0.08% by mass of dietary fiber (citrus fiber) to raw milk, and then inoculating bacteria to ferment to obtain prebiotic yogurt. It can meet consumers' dual needs for taste and health, and is easily accepted by consumers. In order to enrich the types of prebiotic yogurt and meet market demand, partially hydrolyzed mannan can be added to yogurt to develop prebiotic yogurt.
- Aspergillus niger is a heat-resistant filamentous fungus capable of secreting a variety of glycoside hydrolase enzymes.
- the ⁇ -mannanase secreted by it has a variety of excellent enzymatic properties (Harnpicharnchai et al. Bioscience Biotechnology and Biochemistry, 2016, 80: 2298-2305).
- the present invention provides a method for preparing ⁇ -mannanase and its application in preparing partially hydrolyzed mannan and yogurt.
- the present invention first provides a method for preparing a protein with ⁇ -mannanase activity.
- the method includes: introducing the rMan26 gene shown in SEQ ID No. 2 in the sequence list into biological cells to obtain recombinant cells, and culturing In the recombinant cell, the rMan26 gene is expressed to obtain a protein with ⁇ -mannanase activity.
- the expression of the rMan26 gene is driven by a promoter named ATX1, and the ATX1 is (b1), (b2) or (b3):
- (b2) A single-stranded DNA molecule with (b1) substitution and/or deletion and/or addition of one or several nucleotides and 75% or more identical to (b1);
- nucleotide sequence of the rMan26 gene of the present invention can easily use known methods, such as directed evolution and point mutation methods, to mutate the nucleotide sequence of the rMan26 gene of the present invention.
- Those artificially modified nucleotides that have 75% or more identity with the nucleotide sequence of the rMan26 gene of the present invention are all derived from the nucleotide sequence of the present invention and are equivalent to the sequence of the present invention.
- identity refers to sequence similarity to natural nucleic acid sequences. “Identity” includes 75% or higher, 80% or higher, or 85% or higher, or 90% or higher, or 95% or higher with the nucleotide sequence of the rMan26 gene of the present invention, Or a nucleotide sequence of 97% or higher, or 98% or higher, or 99% or higher identity. Identity can be evaluated with the naked eye or computer software. Using computer software, the identity between two or more sequences can be expressed as a percentage (%), which can be used to evaluate the identity between related sequences.
- the stringent conditions can be as follows: 50°C, hybridization in a mixed solution of 7% sodium dodecyl sulfate (SDS), 0.5M NaPO 4 and 1 mM EDTA, at 50°C, 2 ⁇ SSC, 0.1 Rinse in %SDS; it can also be: 50°C, hybridize in a mixed solution of 7% SDS, 0.5M NaPO 4 and 1mM EDTA, and rinse in 50°C, 1 ⁇ SSC, 0.1% SDS; it can also be: 50°C , Hybridize in a mixed solution of 7% SDS, 0.5M NaPO 4 and 1 mM EDTA, and rinse at 50°C, 0.5 ⁇ SSC, 0.1% SDS; it can also be: 50°C, in 7% SDS, 0.5M NaPO 4 and Hybridization in a mixed solution of 1mM EDTA, rinsing at 50°C, 0.1 ⁇ SSC, 0.1% SDS; also: 50°C
- the above-mentioned 75% or more than 75% identity may be 80%, 85%, 90% or more than 95% identity.
- introducing the rMan26 gene shown in SEQ ID No. 2 in the sequence list into a biological cell may include introducing a recombinant vector containing the rMan26 gene and the ATX1 into the biological cell.
- the recombinant vector may be pPAT19K-AnMan26, which is the DNA fragment between the BglII and BamHI recognition sequences of pPIC9K is replaced with a DNA molecule shown in positions 6-930 of SEQ ID No. 4 in the sequence table, And replace the DNA fragment between EcoRI and NotI recognition sequence with the recombinant vector obtained by rMan26 gene.
- the protein can be the following A1), A2) or A3):
- amino acid sequence is the protein of SEQ ID No. 3;
- A2 A protein in which the amino acid sequence shown in SEQ ID No. 3 in the sequence list has been substituted and/or deleted and/or added by one or several amino acid residues and has ⁇ -mannanase function;
- A3 A fusion protein obtained by attaching a tag to the N-terminus or/and C-terminus of A1) or A2).
- amino terminal or carboxyl terminal of the protein consisting of the amino acid sequence shown in SEQ ID No. 3 in the sequence listing can be attached with the tag shown in the following table.
- the protein in A2) above is a protein that is 75% or more identical to the amino acid sequence of the protein shown in SEQ ID No. 3 and has the same function.
- the identity of 75% or more is 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% identity .
- the protein in A2) can be artificially synthesized, or its coding gene can be synthesized first, and then obtained by biological expression.
- the protein coding gene in A2) above can be achieved by deleting one or several amino acid residue codons in the DNA sequence shown in SEQ ID No. 2, and/or performing one or several base pair missense mutations , And/or the coding sequence of the tag shown in the table above is attached to its 5'end and/or 3'end.
- the DNA molecule shown in SEQ ID No. 2 encodes the protein shown in SEQ ID No. 3.
- the protein may be the protein shown in SEQ ID No. 6 in the sequence listing.
- the biological cell may be a microbial cell.
- the microbial cell is a fungus.
- the fungus may be yeast.
- the yeast may be Pichia pastoris (such as Pichia pastoris GS115).
- the recombinant cell is GS115-pPAT19K-AnMan26
- the GS115-pPAT19K-AnMan26 is a recombinant bacteria obtained by introducing the pPAT19K-AnMan26 into Pichia pastoris GS115.
- the invention also provides a protein with ⁇ -mannanase activity prepared by the method for preparing a protein with ⁇ -mannanase activity.
- the invention also provides any of the following products:
- a set of reagents consisting of the rMan26 gene and the ATX1;
- X6 A recombinant vector containing the rMan26 gene and/or the ATX1.
- the set of reagents described in X4 can be used to prepare ⁇ -mannanase.
- the expression cassette of X5 refers to DNA capable of expressing the protein encoded by the rMan26 gene in host cells.
- the DNA may not only include a promoter for initiating the transcription of the rMan26 gene, but also a terminator for terminating the transcription of the rMan26 gene. Further, the expression cassette may also include an enhancer sequence. Promoters that can be used in the present invention include, but are not limited to: constitutive promoters, tissue, organ, and development-specific promoters, and inducible promoters. Specifically, the promoter in the expression cassette of X5 may be the ATX1.
- the recombinant vector of X6 may be the pPAT19K-AnMan26.
- the present invention also provides any of the following applications of the protein:
- the vegetable gum can be b1) or b2) or b3) or b4) or b5): b1) locust bean gum; b2) cassia gum; b3) couma gum; b4) konjac flour; b5) rich Vegetable gum containing mannan.
- the mannose oligosaccharides may be mannose oligosaccharides formed by the polymerization of 2-10 mannoses.
- the "production of mannose oligosaccharides” and “production of partially hydrolyzed mannans” can be mannans or vegetable gums as substrates.
- the vegetable gum is coumadin, and the ratio of the coumadin to the protein with ⁇ -mannanase activity is: 100-200 U of protein with ⁇ -mannanase activity is added per gram of coumadin
- the hydrolysis temperature is 30°C-45°C; the solvent of the coumadin is citric acid buffer or water.
- the vegetable gum may be cassia gum, and the ratio of the cassia gum to the protein with ⁇ -mannase activity is: 100-800 U of the protein with ⁇ -mannanase activity per gram of cassia gum
- the hydrolysis temperature is 30°C-45°C; the solvent of the cassia gum is citric acid buffer or water.
- the invention also provides any of the following applications of the product:
- the vegetable gum can be b1) or b2) or b3) or b4) or b5): b1) locust bean gum; b2) cassia gum; b3) couma gum; b4) konjac flour; b5) rich in mannose Glycan of vegetable gum.
- the partially hydrolyzed mannan prepared by using the protein or the product also belongs to the protection scope of the present invention.
- the vegetable gum for producing the partially hydrolyzed mannan can be c1) or c2) or c3) or c4) or c5): c1) locust bean gum; c2) cassia gum; c3) couma gum; c4 ) Konjac flour; c5) Vegetable gum rich in mannan.
- the preparation of the prebiotic yogurt also includes adding Streptococcus thermophilus and Lactobacillus bulgaricus to the system.
- the present invention also provides a method for making prebiotic yogurt, the method comprising: using the protein or the product to make prebiotic yogurt.
- the system in the above method contains vegetable gum.
- the vegetable gum can be c1) or c2) or c3) or c4) or c5): c1) locust bean gum; c2) cassia gum; c3) couma gum; c4) konjac flour; c5) rich in mannan Of vegetable gum.
- the system of the above method also contains Streptococcus thermophilus and Lactobacillus bulgaricus.
- Figure 1 shows the enzyme production process diagram (A) and SDS-PAGE electrophoresis diagram (B) of recombinant ⁇ -mannanase in high-density fermentation in a 5L fermentor. Among them ( ⁇ ) enzyme activity, ( ⁇ ) protein concentration, ( ⁇ ) wet weight of bacteria. Lane M in B is the protein molecular weight standard, lanes 1-8 are the fermentation supernatants induced 0, 24, 48, 72, 96, 120, 144, 168h, respectively.
- Figure 2 is the purification diagram of recombinant ⁇ -mannanase, where lane 1 is the crude enzyme solution, lane 2 is the pure enzyme purified by Sephacryl S-100HR gel column chromatography, and lane 3 is N-deglycosylation The result of enzyme deglycosylation.
- Figure 3 is a graph showing the optimal pH determination curve of recombinant ⁇ -mannanase. Among them ( ⁇ ) citrate buffer (pH 3.0-6.0), ( ⁇ ) phosphate buffer (pH 6.0-8.0).
- Figure 4 is a graph showing the determination of pH stability of recombinant ⁇ -mannanase. Among them ( ⁇ ) glycine-hydrochloric acid buffer (pH 2.0-3.0), ( ⁇ ) citrate buffer (pH 3.0-6.0), ( ⁇ ) phosphate buffer (pH 6.0-8.0).
- Figure 5 is a graph showing the optimal temperature determination curve of recombinant ⁇ -mannanase.
- Figure 6 is a graph showing the temperature stability determination of recombinant ⁇ -mannanase.
- Fig. 7 is a thin layer chromatography chromatographic analysis diagram of AnMan26 as a product of ⁇ -mannanase hydrolyzed couma gum.
- M, M2, M3, M4, M5, and M6 are mannose, mannobiose, mannotriose, mannotetraose, mannopentaose, and mannohexaose, respectively, and 1 is a partially hydrolyzed coumarin crude sugar liquid.
- Fig. 8 is a gel permeation chromatographic analysis diagram of AnMan26 as a product of ⁇ -mannanase hydrolyzed couma gum. 0min represents unhydrolyzed couma gum.
- Figure 9 is a thin layer chromatography chromatographic analysis diagram of AnMan26 as a product of ⁇ -mannanase water to resolve gelatin.
- M, M2, M3, M4, M5, M6 are respectively mannose, mannobiose, mannotriose, mannotetraose, mannopentaose, mannohexaose, 1 is a partially water-resolved gelatin (cassia oligosaccharide) crude sugar solution.
- Figure 10 is a gel permeation chromatographic analysis diagram of AnMan26 as a product of ⁇ -mannanase water to resolve gelatin. 0min represents unhydrolyzed cassia gum.
- Figure 11 is a diagram showing the influence of the amount of partially hydrolyzed couma gum on the water holding capacity of prebiotic yogurt.
- Streptococcus thermophilus in the following examples is a product of Chr-Hansen, Denmark.
- Lactobacillus bulgaricus is a product of Chr-Hansen, Denmark.
- the expression vector pPIC9K in the following examples is a product of Invitrogen from the United States, and the product number is V17520.
- Pichia pastoris GS115 in the following examples is a product of Invitrogen from the United States, and the product number is C18100.
- the ⁇ -mannanase activity is determined by the 3,5-dinitrosalicylic acid (DNS) method. Unless otherwise specified, the determination steps are as follows: (1) Take 0.9mL 0.5g/100mL locust bean gum solution (using locust Soybean gum and pH 5.0, 50mmol/L citric acid buffer solution), add 0.1mL of appropriately diluted enzyme solution to be tested, and place it in a constant temperature water bath at 45°C for 10 minutes; (2) After completing step (1), use DNS reagent terminates the reaction and reacts with the released reducing sugar, and the amount of reducing sugar (using mannose as the standard) is measured. Draw a standard curve with mannose standard solution.
- the activity unit of ⁇ -mannanase is defined as: under the above reaction conditions, the amount of enzyme required to generate 1 ⁇ mol mannose per minute is one enzyme activity unit (1U).
- Specific enzyme activity is defined as the unit of enzyme activity (U/mg) possessed by 1 mg of protein.
- Locust bean gum Galactomannan, a product of American Sigma-Aldrich company, the product number is G0753.
- Mannose It is a product of American Sigma-Aldrich Company, the article number is M2069.
- ⁇ -mannanase gene XM_001397260.1
- MAN26 gene The coding region of ⁇ -mannanase gene (MAN26 gene) XM_001397260.1 is 954bp, and its sequence is the ⁇ -mannanase shown in SEQ ID No. 1 in the sequence table and SEQ ID No. 3 in the coding sequence table MAN26.
- the MAN26 gene is codon optimized, and the optimized gene is obtained, which is recorded as the rMan26 gene, and its sequence is SEQ ID No. 2 in the sequence table.
- the rMan26 gene was artificially synthesized and used as a template to perform PCR amplification with specific primers rMan26AF and rMan26AR to obtain a PCR product.
- the primer sequence is as follows:
- rMan26AF 5'-CCG GAATTC GCTTCTAACCAAACTTTGTCTTACG-3' (underlined is the restriction enzyme EcoRI restriction site) (SEQ ID No. 7);
- rMan26AR 5'-GAAT GCGGCCGC TTAAGCACCTTCCCAATTCAAAG-3' (underlined is the restriction endonuclease NotI restriction site) (SEQ ID No. 8).
- pPAT19K-AnMan26 is to replace the DNA fragment between the recognition sequence of BglII and BamHI of pPIC9K with the DNA molecule shown at positions 6-930 of SEQ ID No. 4 in the sequence list, and replace the DNA fragment between the recognition sequence of EcoRI and NotI It is a recombinant vector derived from rMan26 gene.
- pPAT19K-AnMan26 contains the DNA molecule shown in SEQ ID No. 5 in the sequence table (that is, the fusion gene formed by the rMan26 gene and a partial sequence on the vector, recorded as AnMan26 gene), and can express the DNA molecule shown in SEQ ID No. 6 in the sequence table
- the fusion protein of is denoted as recombinant ⁇ -mannanase (AnMan26), and the expression of AnMan26 gene is driven by ATX1.
- the 280-1233 of SEQ ID No. 5 in the sequence list is the sequence of the rMan26 gene, and the 1-279 is the sequence on the vector; the 94-410 of SEQ ID No. 6 is the amino acid sequence of MAN26, and the Position 1-93 is the polypeptide encoded by the sequence on the vector.
- step 4 Collect the recombinant bacterial cells from step 3 with sterile water, and spread the appropriately diluted bacterial cells on YPD plates containing G418 at the concentrations of 1 mg/mL, 2 mg/mL, 3 mg/mL, and 4 mg/mL ( 1g/100mL yeast extract, 2g/100mL tryptone, 2g/100mL glucose), select single colonies that grow well at different G418 concentrations, and inoculate them in 5mL BMGY medium (the medium is composed of solvent and solute.
- the solute and its concentration in the culture medium are 1g/100mL yeast extract, 2g/100mL peptone, 1.34g/100mL YNB (American Biomol product), 4 ⁇ 10 -5 g /100mL biotin and 1g/100mL glycerol), placed in 30°C, 200rpm shaker, shake culture, when the OD 600 is 2-6, centrifuge, discard the supernatant, collect the bacteria and transfer to 10mL BMMY culture Base (this medium is a medium obtained by replacing glycerol in BMGY medium with methanol, and the concentration of methanol in this medium is 0.5% (volume percentage)), placed in a shaker at 30°C and 200 rpm to induce expression .
- this medium is a medium obtained by replacing glycerol in BMGY medium with methanol, and the concentration of methanol in this medium is 0.5% (volume percentage)
- the fermentation tank is a 5L fermentation tank.
- Seed medium BMGY, minimal medium BSM, glycerol fed-batch medium and 100% methanol induction medium are all configured according to the method in the literature.
- the whole fermentation process is divided into four stages: seed liquid culture, basic culture, glycerol fed-batch culture and 100% methanol induction culture. Specific steps are as follows:
- Seed culture inoculate GS115-pPAT19K-AnMan26 into a 500 mL Erlenmeyer flask containing 150 mL of BMGY medium, and cultivate it in a shaker at 30° C. and 200 rpm for more than 24 hours to obtain a seed solution with an OD 600 of 2-6.
- Basic culture Inoculate the seed solution in 1) into a 5L sterilized fermentor (containing 1.5L of basic fermentation medium BSM), adjust the pH of the medium to 4.0 with ammonia, and add PTM1 4.35mL/L to start Fermentation broth, seed broth inoculum amount is 10%, the temperature during the culture process is 30°C, the rotation speed is 600rpm, when the dissolved oxygen DO value rises rapidly, and the glycerol is exhausted, it enters the glycerol fed culture stage.
- BSM basic fermentation medium
- Glycerin fed-batch culture the glycerin aqueous solution (glycerol concentration is 500g/L) flow acceleration is 30mL/h/L starting fermentation broth. Dissolved oxygen is always monitored at this stage, and the dissolved oxygen is maintained at DO>20% by adjusting the acceleration of the glycerin flow.
- the temperature is controlled at 30°C and the pH of the fermentation broth is 4.0. When the wet weight of the bacteria reaches 180-220g/L, the feeding is stopped. The fermentation time of the whole process is 4-6h.
- 100% methanol feeding stage After stopping feeding glycerol, starve for about 30 minutes to exhaust the glycerin in the tank, adjust the pH of the fermentation broth to 6.0, rotate the speed to 800rpm, start feeding 100% methanol to induce enzyme production, and methanol is fed Increase from 3.6mL/h/L initial fermentation broth to 10.9mL/h/L initial fermentation broth, monitor the dissolved oxygen DO in the tank> 20% (if the dissolved oxygen DO is less than 20%, the flow acceleration can be appropriately reduced), Control the temperature at 30°C and ferment for 6-7 days.
- wet weight of the bacteria m 2 -m 1 .
- Protein content Using bovine serum albumin as the standard protein, the Lowry method (Lowry et al. The Journal of Biological Chemistry, 1951, 193(1): 265-275) is used to determine the protein content (mg/mL). The protein content is the total protein content.
- the wet weight, protein content and ⁇ -mannanase enzyme activity changes are shown in Figure 1 A, and the SDS-PAGE electrophoresis of the protein during the fermentation process is shown in Figure 1 B.
- the enzyme activity reached the highest in the high-density fermentation for 168h.
- the ⁇ -mannanase enzyme activity in the supernatant of the fermentation broth was 22100U/mL, the protein content was 12.0mg/mL, and the wet weight of the bacteria was 355.8g/L.
- the fermentation supernatant ie crude enzyme solution
- 20mmol/L citrate buffer pH 5.0
- the enzyme solution was concentrated to 0.6mL with a 10kDa ultrafiltration membrane, the concentrated sample was centrifuged at 11510 ⁇ g for 5min, and the supernatant was collected.
- N-deglycosylation enzyme deglycosylation The steps of N-deglycosylation enzyme deglycosylation are as follows:
- glycoprotein denaturation buffer (10 ⁇ ) (product of NEB, USA, product number P0702S).
- GlycoBuffer3 (10 ⁇ ) (product of NEB, USA, item number P0702S).
- the recovery rate refers to the percentage of the total enzyme activity of the pure enzyme in the total enzyme activity of the crude enzyme solution.
- the purification factor refers to the ratio of the specific enzyme activity of the pure enzyme to the specific enzyme activity of the crude enzyme.
- Example 2 Enzymatic properties of recombinant protein AnMan26 as ⁇ -mannanase
- the buffers used are as follows: glycine-hydrochloric acid buffer (pH 2.0, 2.5 and 3.0), citrate buffer (pH 3.0, 3.5, 4.0, 4.5, 5.0, 5.5 and 6.0), phosphate buffer (pH 6.0, 6.5) , 7.0, 7.5 and 8.0).
- concentrations of the above buffers are all 50mmol/L.
- the purified recombinant ⁇ -mannanase solution prepared in Example 1 was used as the sample solution to be tested, and the enzyme activity was determined as follows: Take 0.9mL 0.5g/100mL locust bean gum solution (using locust bean gum and pH 3.0 -8.0 range of different buffer systems to be tested), add 0.1mL of appropriately diluted enzyme solution to be tested, and place the resulting reaction system at 30°C for 10 minutes to determine the enzyme activity. Record the highest enzyme activity as 100%. The relative activity of ⁇ -mannanase under various pH conditions was calculated. As shown in Figure 3, the optimal pH value of recombinant ⁇ -mannanase was 5.0.
- the recombinant ⁇ -mannanase prepared in Example 1 has a citric acid buffer solution at pH 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, and 6.0, and a phosphate buffer solution at pH 6.0, 6.5, 7.0, 7.5, and 8.0, respectively
- the relative enzyme activities in the liquid were 1.4% ⁇ 0.4%, 20.5% ⁇ 0.5%, 44.7% ⁇ 0.5%, 77.9% ⁇ 1.3%, 100% ⁇ 0.4%, 87.6% ⁇ 0.7%, 54.7% ⁇ 0.3%, 36.3% ⁇ 0.3%, 17.9% ⁇ 0.9%, 3.7% ⁇ 0.1%, 0.7% ⁇ 0.03% and 0.2% ⁇ 0.02%.
- the purified recombinant ⁇ -mannanase solution prepared in Example 1 was diluted with the above-mentioned buffer by an appropriate multiple, so that the recombinant ⁇ -mannanase was placed in the above-mentioned buffer at each pH, and then the diluted The enzyme solution was placed in a water bath at 30°C for 30 minutes, then quickly taken out and immediately ice-bathed for 30 minutes to determine the residual ⁇ -mannanase activity.
- the control is the dilution of the recombinant ⁇ -mannanase solution (ie the recombinant ⁇ -mannanase obtained in Example 1) without the above treatment (the above treatment refers to the first 30°C water bath for 30 minutes, and then the rapid ice bath for 30 minutes). Dilution of pure enzyme solution). Taking the enzyme activity of the control as 100%, the relative activity of the enzyme after treatment with different pH buffers was calculated. The result is shown in Figure 4. The enzyme remained stable in the pH range of 2.5-6.0, and the residual enzyme activity remained stable after 30 minutes of treatment. Keep it above 80%.
- Example 1 The recombinant ⁇ -mannanase prepared in Example 1 was subjected to a glycine-hydrochloric acid buffer with pH of 2.0, 2.5, and 3.0, a citric acid buffer with a pH of 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, and 6.0, respectively.
- the relative enzyme activities after treatment with phosphate buffer with pH 6.0, 6.5, 7.0, 7.5 and 8.0 were 9.4% ⁇ 0.2%, 78.9% ⁇ 2.3%, 82.3% ⁇ 5.1%, 96.2% ⁇ 3.7%, 91.0%, respectively ⁇ 2.4%, 92.7% ⁇ 3.7%, 92.2% ⁇ 5.1%, 93.5% ⁇ 2.8%, 92.5 ⁇ 1.6%, 95.7% ⁇ 4.3%, 69.4% ⁇ 3.0%, 66.6% ⁇ 2.1%, 65.4% ⁇ 2.3% , 59.0% ⁇ 2.1% and 26.0% ⁇ 1.0%.
- the recombinant ⁇ -mannanase solution prepared in Example 1 was used as the enzyme solution to be tested, and the pH 5.0, 50mmol/L citric acid buffer system was used to react at different temperatures in the range of 30°C to 80°C to determine the difference For the enzyme activity at temperature, take the highest enzyme activity as 100%, and calculate the relative activity at each reaction temperature. The results are shown in Figure 5, the optimal temperature of recombinant ⁇ -mannanase is 45°C.
- the recombinant ⁇ -mannanase prepared in Example 1 operates at 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C and 80°C
- the relative enzyme activities at °C were 42.0% ⁇ 3.6%, 42.7% ⁇ 3.7%, 66.6% ⁇ 5.0%, 72.5% ⁇ 5.4%, 80.6% ⁇ 2.7%, 100% ⁇ 2.0%, 79.2% ⁇ 4.6%, 40.2% ⁇ 2.1%, 18.6% ⁇ 0.6%, 9.8% ⁇ 1.7%, 7.2% ⁇ 0.5%, 6.1% ⁇ 0.2%, and 4.6% ⁇ 0.3%.
- the recombinant ⁇ -mannanase solution prepared in Example 1 was diluted with pH 5.0, 50mmol/L citric acid buffer to an appropriate multiple, and placed in a water bath at different temperatures for 30 minutes (water bath temperature was 20°C, 25°C, 30 °C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C or 80°C), quickly take out and ice bath for 30min, and determine the residual ⁇ -mannanase activity .
- the control is a recombinant ⁇ -mannanase solution dilution that has not been processed by the above steps (the above treatment refers to a water bath for 30 minutes and a rapid ice bath for 30 minutes). Take the control enzyme activity as 100%.
- the relative activity results of the test enzyme solution after the above-mentioned various temperature treatments are shown in Fig. 6.
- the recombinant ⁇ -mannanase retains more than 80% of the activity below 40°C.
- the recombinant ⁇ -mannanase prepared in Example 1 was subjected to 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C and 80°C
- the relative enzyme activities after °C treatment were 100% ⁇ 3.7%, 100% ⁇ 3.8%, 100% ⁇ 4.0%, 100% ⁇ 3.9%, 93.8% ⁇ 5.5%, 73.8% ⁇ 4.0%, 19.4% ⁇ 0.3% , 12.6% ⁇ 1.9%, 3.6% ⁇ 0.3%, 1.7% ⁇ 0.1%, 1.4% ⁇ 0.1%, 1.2% ⁇ 0.1% and 1.1% ⁇ 0.1%.
- the recombinant ⁇ -mannanase solution prepared in Example 1 was used as the test enzyme solution to determine the ⁇ -mannanase activity of different substrates.
- the substrates were locust bean gum, konjac flour, cassia gum, coumadin and The concentration of carboxymethyl cellulose and the substrate in the reaction system are both 0.5g/100mL.
- konjac flour is a product of Hubei Qiangsen Konjac Technology Co., Ltd., the item number is KJ-30; cassia gum is a product of Beijing Guarrun Technology Co., Ltd.; coumadin is a product of Beijing Guarrun Technology Co., Ltd.; carboxymethyl
- the cellulose is a product of Sigma-Aldrich, USA, and the product number is C4888-500G.
- Recombinant ⁇ -mannanase has the highest specific enzyme activity for locust bean gum, reaching 2869.0 U/mg; followed by konjac flour, with a specific enzyme activity of 1905.0 U/mg; the specific enzyme activity for couma gum is the lowest, at 341.1 U /mg, no hydrolysis ability to carboxymethyl cellulose.
- Example 3 Using recombinant ⁇ -mannanase (AnMan26) to hydrolyze couma gum to produce partially hydrolyzed couma gum
- the reaction system was inactivated in a boiling water bath for 20 minutes, centrifuged at 11510 ⁇ g for 10 minutes, and the precipitate and the supernatant were collected.
- the precipitate was the hydrolysate residue, and the supernatant was the partially hydrolyzed coumarin crude sugar solution.
- the 3,5-dinitrosalicylic acid method was used to determine the reducing sugar content in the crude sugar solution, and the reducing sugar yield, hydrolysis rate and product yield were calculated.
- the composition of the crude sugar liquid was qualitatively analyzed by thin-layer chromatography.
- the weight-average molecular weight of partially hydrolyzed couma gum was analyzed by gel permeation chromatography.
- Reducing sugar yield (%) total reducing sugar mass in the system after hydrolysis / dry weight of raw materials added before hydrolysis ⁇ 100%;
- Hydrolysis rate (%) (dry weight of raw materials added before hydrolysis-dry weight of hydrolysate residue)/dry weight of raw materials added before hydrolysis ⁇ 100%. Remeasured
- Product yield (%) product dry weight/dry weight of raw materials added before hydrolysis ⁇ 100%, product dry weight is measured by placing the partially hydrolyzed couma gum crude sugar liquid in an oven at 105°C to a constant weight.
- the standard control is a mixture of standard products of mannose, mannobiose, mannotriose, mannotetraose, mannopentaose and mannohexaose. Place an appropriate amount of the sample to be tested on the thin-layer chromatography chromatographic analysis plate, put the layering agent in the layer twice, completely soak and blow dry with the developer, and bake at 130°C for color development.
- mannose is produced by Sigma-Aldrich in the United States, the product number is M2069; mannobiose, mannotriose, mannotetraose, mannopentaose and mannohexaose are all Irish Megazyme products, and the product numbers are O-MBI and O-MTR respectively. , O-MTE, O-MPE, O-MHE.
- Gel permeation chromatography detection conditions TSKgel GMPW XL aqueous gel chromatography column (7.8 ⁇ 300mm); column temperature: 60°C; RID detector; injection volume: 20 ⁇ L; mobile phase: 100 mM NaNO 3 ; flow rate: 0.6 mL/ min; Use polyoxyethylene standard product (molecular weight 300-500000Da, product of Japan Tosoh Corporatio) to make the standard curve.
- ⁇ -mannanase can hydrolyze couma gum to produce partially hydrolyzed couma gum with a yield of 73.5%.
- the composition is mannose oligosaccharides with a degree of polymerization of 2-6, and a large amount of polymerization degree is greater than 6. Mannan.
- the average degree of polymerization of partially hydrolyzed couma gum is less than or equal to 10, and the weight average molecular weight is 1.8 ⁇ 10 3 Da.
- Example 4 Using recombinant ⁇ -mannanase (AnMan26) water to solve gelatin production and partial water solution to gelatin (cassia oligosaccharide)
- the reaction system is heated in a boiling water bath to inactivate the enzyme for 20 minutes to obtain an enzymatic hydrolysate. After centrifuging the enzymatic hydrolysate at 11510 ⁇ g for 10 min, the supernatant is collected as the crude sugar solution.
- the 3,5-dinitrosalicylic acid method was used to determine the reducing sugar content in the crude sugar solution, and the reducing sugar yield, hydrolysis rate and product yield were calculated.
- the composition of the crude sugar liquid was qualitatively analyzed by thin-layer chromatography. Gel permeation chromatography was used to analyze part of the water to solve the weight average molecular weight of gelatin (cassia oligosaccharide).
- the calculation method of reducing sugar yield, hydrolysis rate and product yield, TLC chromatographic conditions and gel permeation chromatographic analysis conditions are the same as in Example 3.
- the results of gel permeation chromatography analysis are shown in Figure 10.
- the weight-average molecular weight of cassia gum is 1.7 ⁇ 10 6 Da.
- part of the water resolves the rapid decline of the weight-average molecular weight of gelatin gum.
- the weight-average molecular weight is 1188 Da.
- ⁇ -mannanase can produce partial water-resolved gelatin (cassia oligosaccharides) with a yield of 74.7%.
- the main components are mannose oligosaccharides with a degree of polymerization of between 1-6. Mannan with a degree of polymerization greater than 6.
- the average degree of polymerization of partial water solution gelatin gum is less than 7, and the weight average molecular weight is 1188 Da.
- Example 5 Using partially hydrolyzed mannan to produce prebiotic yogurt
- the partially hydrolyzed mannan used in this example is the partially hydrolyzed couma gum obtained in Example 3.
- Partially hydrolyzed couma gum powder is spray-dried to obtain partially hydrolyzed couma gum powder (spray drying conditions: air inlet temperature 180°C, air outlet temperature 80°C).
- Partially hydrolyzed mannan to produce prebiotic yogurt is made from the following raw materials (1000 parts) by weight: 925-910 parts of fresh milk, 5-20 parts of partially hydrolyzed couma gum powder, and 70 parts of sucrose.
- the first step mix fresh milk, partially hydrolyzed couma gum and sucrose according to the above weight parts, and then preheat at 65°C until the material is completely dissolved, homogenize at 40MPa, and pasteurize at 95°C for 5 minutes to obtain a mixture.
- the second step After cooling the mixture to 40°C, add Streptococcus thermophilus and Lactobacillus bulgaricus for inoculation.
- the contents of the two added bacteria in the system are both 1 ⁇ 10 6 cfu/ml.
- the third step Put the inoculated mixture in a constant temperature fermentation room and ferment at 42°C for 4 hours (to pH 4.6).
- the fourth step demulsify the prebiotic yogurt obtained by fermentation at 350 rpm for 1 min, chill it to 20°C, put it in the refrigerator and cook for 16 hours to obtain the yogurt.
- Water holding capacity take the yogurt that has been ripened for 16 hours for determination, weigh the mass of the sterilized centrifuge tube and record it as m 1 , add 20 g of yogurt to each centrifuge tube and weigh the total mass, record it as m 2 , use a centrifuge Centrifuge at 3000 rpm for 10 minutes, discard the supernatant, and weigh the centrifuge tube and the lower layer as m 3 .
- water holding capacity (%) (m 3 -m 1 )/(m 2 -m 1 ) ⁇ 100%.
- Counting of Streptococcus thermophilus Choose 2-3 consecutive appropriate dilutions, and draw 1 mL of sample homogenate into a sterilized dish for each dilution. After transferring the diluent into the petri dish, pour the MC medium cooled to 48°C into the petri dish about 15 mL, and rotate the petri dish to make the mixture uniform. 36°C ⁇ 1°C aerobic culture for 72h ⁇ 2h, count after culture.
- Lactobacillus count select 2-3 consecutive appropriate dilutions, and draw 1 mL of sample homogenate into a sterilized petri dish for each dilution. After transferring the diluent into the petri dish, pour the MRS agar medium cooled to 48°C into the petri dish for about 15 mL, and rotate the petri dish to make the mixture uniform. Anaerobic culture at 36°C ⁇ 1°C for 72h ⁇ 2h, count after culture.
- Table 3 is the sensory evaluation data of yogurt with partially hydrolyzed couma The score is 6.6.
- the main difference is that the flavor and viscosity score of yogurt with partially hydrolyzed couma gum is lower than that of yogurt without partially hydrolyzed couma gum.
- the total score of yogurt with 1% partially hydrolyzed couma gum is 6.3, which is close to the total score of yogurt without partially hydrolyzed couma gum, 6.6, and can be used in the production of prebiotic yogurt.
- the mixture in Table 1 is made of the following raw materials (1000 parts) by weight: 925-910 parts of fresh milk, 5-20 parts of partially hydrolyzed couma gum powder, and 70 parts of sucrose.
- Figure 11 shows the water retention results of partially hydrolyzed couma gum yogurt. It can be seen from Figure 11 that the water retention capacity of yogurt after adding partially hydrolyzed couma gum is between 36.8% and 38.6%, which is higher than that of yogurt without partially hydrolyzed couma gum. The water holding capacity is 34.7%.
- the amount of partially hydrolyzed couma gum is 0-2.0%
- the water holding capacity of yogurt increases with the increase of the amount of partially hydrolyzed couma gum, indicating that the addition of partially hydrolyzed couma gum helps to increase the water holding capacity of yogurt
- the addition of partially hydrolyzed couma gum can effectively enhance the gel structure of yogurt, make the yogurt more effectively retain water, prevent the precipitation of whey, and improve the tissue state of the yogurt.
- Table 4 shows the effect of partially hydrolyzed coumadin yogurt on the viable counts of Lactobacillus and Streptococcus thermophilus. It can be seen from Table 4 that the number of viable lactobacilli and the viable number of Streptococcus thermophilus in the yogurt without adding partially hydrolyzed couma gum are 1.1 ⁇ 10 8 CFU/mL and 2.75 ⁇ 10 8 CFU/mL, respectively , And the number of viable lactobacilli in the yogurt after adding partially hydrolyzed couma gum is between 4.05 ⁇ 10 8 CFU/mL-1.075 ⁇ 10 9 CFU/mL, and the number of viable streptococcus thermophilus is 2.82 ⁇ 10 8 CFU /mL-6.9 ⁇ 10 8 CFU/mL, which is higher than the number of viable bacteria of Lactobacillus and the number of Streptococcus thermophilus in yogurt without partially hydrolyzed couma gum.
- the number of viable lactobacilli in yogurt increased first and then decreased with the increase of the amount of partially hydrolyzed coumarin.
- the number of viable streptococcus thermophilus in yogurt With the increase of the amount of partially hydrolyzed couma gum, the number of Lactobacilli in the yogurt is the highest 1.075 ⁇ 10 9 CFU/mL when 1.5% partially hydrolyzed couma gum is added, and in the yogurt when 2.0% partially hydrolyzed couma gum is added
- the highest number of viable bacteria of Streptococcus thermophilus is 6.9 ⁇ 10 8 CFU/mL.
- the number of viable bacteria of Lactobacillus and Streptococcus thermophilus in the partially hydrolyzed couma gum yogurt were higher than those of Lactobacillus and Streptococcus thermophilus without the addition of partially hydrolyzed couma gum yogurt. It shows that the addition of partially hydrolyzed couma gum can effectively increase the number of viable bacteria of Lactobacillus and Streptococcus thermophilus in yogurt, and improve the quality of yogurt.
- the present invention optimizes the codon of Aspergillus niger ⁇ -mannanase, and transforms the pAOX1 promoter to obtain the pATX1 promoter and construct the expression vector pATX19K to transform into Pichia pastoris GS115 for high-density expression, thereby obtaining high-enzyme activity ⁇ -mannanase, its enzyme activity can reach 22100U/mL.
- the optimal pH of the ⁇ -mannanase obtained in the present invention is 5.0, and the optimal temperature of the enzyme is 45°C. It can solve the mannan-rich vegetable gums such as gelatin and couma gum, and obtain different polymerization degrees.
- the partially hydrolyzed mannan of mannose oligosaccharides is significantly different from the existing ⁇ -mannanase water solution gelatin and coumadin, which can enrich the partially hydrolyzed mannan market.
- Partially hydrolyzed mannan is added to yogurt to prepare prebiotic yogurt, which can increase the water holding capacity of yogurt, the number of viable bacteria of Lactobacillus and Streptococcus thermophilus, and improve the quality of yogurt.
- the ⁇ -mannanase of the present invention and the preparation method thereof have great application value in the food industry.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
标签 | 残基 | 序列 |
Poly-Arg | 5-6(通常为5个) | RRRRR |
Poly-His | 2-10(通常为6个) | HHHHHH |
FLAG | 8 | DYKDDDDK |
Strep-tag II | 8 | WSHPQFEK |
c-myc | 10 | EQKLISEEDL |
Claims (20)
- 一种具有β-甘露聚糖酶活性的蛋白质的制备方法,包括:将序列表中SEQ ID No.2所示的rMan26基因导入生物细胞中,得到重组细胞,培养所述重组细胞,使所述rMan26基因得到表达,得到具有β-甘露聚糖酶活性的蛋白质。
- 根据权利要求1所述的方法,其特征在于:所述rMan26基因的表达由名称为ATX1的启动子驱动,所述ATX1为(b1)、(b2)或(b3):(b1)序列表中SEQ ID No.4的第6-930位所示的DNA分子;(b2)将(b1)经过一个或几个核苷酸的取代和/或缺失和/或添加且与(b1)具有75%或75%以上同一性的单链DNA分子;(b3)在严格条件下与(b1)或(b2)限定的核苷酸序列杂交的DNA分子。
- 根据权利要求1或2所述的方法,其特征在于:所述生物细胞为微生物细胞。
- 根据权利要求3所述的方法,其特征在于:所述微生物细胞为真菌。
- 根据权利要求4所述的方法,其特征在于:所述真菌为酵母。
- 根据权利要求1或2所述的方法,其特征在于:所述蛋白质为如下A1)、A2)或A3):A1)氨基酸序列是SEQ ID No.3的蛋白质;A2)将序列表中SEQ ID No.3所示的氨基酸序列经过一个或几个氨基酸残基的取代和/或缺失和/或添加且具有β-甘露聚糖酶功能的蛋白质;A3)在A1)或A2)的N端或/和C端连接标签得到的融合蛋白质。
- 根据权利要求6所述的方法,其特征在于:所述生物细胞为微生物细胞。
- 根据权利要求7所述的方法,其特征在于:所述微生物细胞为真菌。
- 根据权利要求8所述的方法,其特征在于:所述真菌为酵母。
- 利用权利要求1-9中任一所述方法制备的具有β-甘露聚糖酶活性的蛋白质。
- 下述任一产品:X1、权利要求1-9中任一所述重组细胞;X2、权利要求1中所述rMan26基因;X3、权利要求2中所述ATX1;X4、由权利要求1中所述rMan26基因和权利要求2中所述ATX1组成的成套试剂;X5、含有权利要求1中所述rMan26基因和/或权利要求2中所述ATX1的表达盒;X6、含有权利要求1中所述rMan26基因和/或权利要求2中所述ATX1的重组载体。
- 权利要求1-9中任一所述蛋白质的下述任一应用:a1)作为β-甘露聚糖酶的应用;a2)在制备有β-甘露聚糖酶活性产品中的应用;a3)在制备甘露寡糖中的应用;a4)在制备用于制备甘露寡糖产品中的应用;a5)在降解甘露聚糖中的应用;a6)在制备用于降解甘露聚糖产品中的应用;a7)在制备部分水解甘露聚糖中的应用;a8)在制备用于制备部分水解甘露聚糖产品中的应用;a9)在降解植物胶中的应用;a10)在制备用于降解植物胶产品中的应用。
- 根据权利要求12所述的应用,其特征在于:所述植物胶为b1)或b2)或b3)或b4)或b5):b1)槐豆胶;b2)决明子胶;b3)香豆胶;b4)魔芋粉;b5)富含甘露聚糖的植物胶。
- 权利要求11所述产品的下述任一应用:a2)在制备有β-甘露聚糖酶活性产品中的应用;a3)在制备甘露寡糖中的应用;a4)在制备用于制备甘露寡糖产品中的应用;a5)在降解甘露聚糖中的应用;a6)在制备用于降解甘露聚糖产品中的应用;a7)在制备部分水解甘露聚糖中的应用;a8)在制备用于制备部分水解甘露聚糖产品中的应用;a9)在降解植物胶中的应用;a10)在制备用于降解植物胶产品中的应用。
- 根据权利要求14所述的应用,其特征在于:所述植物胶为b1)或b2)或b3)或b4)或b5):b1)槐豆胶;b2)决明子胶;b3)香豆胶;b4)魔芋粉;b5)富含甘露聚糖的植物胶。
- 利用权利要求1-9中任一所述蛋白质或权利要求11所述产品制备的部分水解甘露聚糖。
- 利用权利要求1-9中任一所述的蛋白质制备部分水解甘露聚糖在制作益生元酸奶中的应用。
- 根据权利要求17所述的应用,其特征在于:生产所述部分水解甘露聚糖的植物胶为c1)或c2)或c3)或c4)或c5):c1)槐豆胶;c2)决明子胶;c3)香豆胶;c4)魔芋粉;c5)富含甘露聚糖的植物胶。
- 根据权利要求17或18所述的应用,其特征在于:所述益生元酸奶制备中还包括向体系中添加嗜热链球菌(Streptococcus thermophilus)和保加利亚乳杆菌(Lactobacillus bulgaricus)。
- 制作益生元酸奶的方法,包括:利用权利要求1-9中任一所述的蛋白质或权利要求11所述产品制作益生元酸奶。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010354187.0A CN111484989A (zh) | 2020-04-29 | 2020-04-29 | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 |
CN202010354187.0 | 2020-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021218171A1 true WO2021218171A1 (zh) | 2021-11-04 |
Family
ID=71791911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2020/135515 WO2021218171A1 (zh) | 2020-04-29 | 2020-12-11 | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111484989A (zh) |
WO (1) | WO2021218171A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111484989A (zh) * | 2020-04-29 | 2020-08-04 | 中国农业大学 | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 |
KR20230115115A (ko) * | 2022-01-26 | 2023-08-02 | 씨제이제일제당 (주) | 만난아제 활성을 갖는 변이형 폴리펩티드 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101724614A (zh) * | 2010-01-12 | 2010-06-09 | 中南大学 | 一种酸性β-甘露聚糖酶、基因、工程菌及其构建 |
CN102676477A (zh) * | 2011-08-19 | 2012-09-19 | 济南诺能生物工程有限公司 | 酸性β-甘露聚糖酶基因改造及其工程菌的构建 |
CN109735547A (zh) * | 2019-03-19 | 2019-05-10 | 青岛蔚蓝生物集团有限公司 | 一种提高毕赤酵母外源蛋白表达量的启动子及其应用 |
CN110029122A (zh) * | 2019-03-19 | 2019-07-19 | 青岛蔚蓝生物集团有限公司 | 一种甘露聚糖酶高产菌株及其应用 |
CN111484989A (zh) * | 2020-04-29 | 2020-08-04 | 中国农业大学 | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108220271B (zh) * | 2018-01-25 | 2020-05-19 | 中国农业大学 | 蛋白质AxMan113A作为β-甘露聚糖酶的应用 |
-
2020
- 2020-04-29 CN CN202010354187.0A patent/CN111484989A/zh active Pending
- 2020-12-11 WO PCT/CN2020/135515 patent/WO2021218171A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101724614A (zh) * | 2010-01-12 | 2010-06-09 | 中南大学 | 一种酸性β-甘露聚糖酶、基因、工程菌及其构建 |
CN102676477A (zh) * | 2011-08-19 | 2012-09-19 | 济南诺能生物工程有限公司 | 酸性β-甘露聚糖酶基因改造及其工程菌的构建 |
CN109735547A (zh) * | 2019-03-19 | 2019-05-10 | 青岛蔚蓝生物集团有限公司 | 一种提高毕赤酵母外源蛋白表达量的启动子及其应用 |
CN110029122A (zh) * | 2019-03-19 | 2019-07-19 | 青岛蔚蓝生物集团有限公司 | 一种甘露聚糖酶高产菌株及其应用 |
CN111484989A (zh) * | 2020-04-29 | 2020-08-04 | 中国农业大学 | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 |
Non-Patent Citations (5)
Title |
---|
DATABASE Protein 12 June 2018 (2018-06-12), ANONYMOUS: "glycoside hydrolase [Aspergillus niger CBS 101883]", XP055861922, retrieved from Genbank Database accession no. PYH51711 * |
KONDO SHIZUKI, XIAO JIN-ZHONG, TAKAHASHI NORITOSHI, MIYAJI KAZUHIRO, IWATSUKI KEIJI, KOKUBO SADAYUKI: "Suppressive Effects of Dietary Fiber in Yogurt on the Postprandial Serum Lipid Levels in Healthy Adult Male Volunteers", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 68, no. 5, 1 January 2014 (2014-01-01), JP, pages 1135 - 1138, XP055861943, ISSN: 0916-8451, DOI: 10.1271/bbb.68.1135 * |
LI ZHEZHE: "Expression and Characterization of Mannanase from Aspergillus Niger CBS 513.88 in Pichia Pastoris", CHINESE MASTER'S THESES FULL-TEXT DATABASE, 15 May 2019 (2019-05-15), pages 1 - 62, XP055861937 * |
SHI YUQIN;YANG SHAOQING;LI YANXIAO;LIU JUN;YAN QIAOJUAN;JIANG ZHENGQIANG: "Effect of Guar Gum on the Growth of Lactic Acid Bacteria and the Quality of Yogurt", JOURNAL OF FOOD SCIENCE AND BIOTECHNOLOGY, vol. 38, no. 1, 15 January 2019 (2019-01-15), pages 29 - 35, XP055861931, ISSN: 1673-1689, DOI: 10.3969/j.issn.1673-1689.2019.01.005 * |
WEI ZHAO; JIA ZHENG; HONG-BO ZHOU: "A Thermotolerant and Cold-active Mannan Endo-1, 4-β-mannosidase from Aspergillus Niger CBS 513.88: Constitutive Overexpression and High-denisty Fermentation in Pichia Pastoris", BIORESOURCE TECHNOLOGY, vol. 102, no. 16, 20 April 2011 (2011-04-20), pages 7538 - 7547, XP028232557, ISSN: 0960-8524, DOI: 10.1016/j.biortech.2011.04.070 * |
Also Published As
Publication number | Publication date |
---|---|
CN111484989A (zh) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ding et al. | High-activity production of xylanase by Pichia stipitis: purification, characterization, kinetic evaluation and xylooligosaccharides production | |
FI128699B (en) | Herbal food product and process | |
WO2017197546A1 (zh) | 一种β-甘露聚糖酶mRmMan5A及其编码基因与应用 | |
WO2021218171A1 (zh) | 一种β-甘露聚糖酶的制备方法及在制备部分水解甘露聚糖中的应用 | |
CN101012457A (zh) | 制备耐热木聚糖酶、耐热β-木糖苷酶或耐热β-葡萄糖苷酶的方法 | |
IL179238A (en) | Prebiotic comprising hydrolyzed konjac glucomannan, method of manufacture thereof, use thereof in preparation of medicaments for treating infections and food stuff comprising the same | |
CN109679864B (zh) | 一种产转糖基活性β-半乳糖苷酶的菌株及用该酶生产低聚半乳糖的方法 | |
JP5047917B2 (ja) | バチルス・リケニホルミスb1菌株、当該菌株を用いて得られる好アルカリ性酵素液及びその製造方法 | |
CN108041383B (zh) | 一种具有银耳典型性风味的高营养银耳饮料及其制备方法 | |
CN104178472B (zh) | 降解纤维素的酶及其构建和应用 | |
CN106615116A (zh) | 具有益生功能的开菲尔酸奶及其制备方法 | |
JP2001507221A (ja) | 新規エンドグルカナーゼ | |
CN107475273B (zh) | 新几丁质酶p1724及其应用 | |
CN111593034B (zh) | 利用β-1,6-葡聚糖酶制备低聚龙胆糖的方法及其应用 | |
CN115216460B (zh) | 一种米黑根毛霉糖苷水解酶12家族木葡聚糖酶的制备方法及应用 | |
CN101481696B (zh) | 一种适冷内切β-木聚糖酶的基因XynA及应用 | |
CN107236692B (zh) | 白蚁溶纤维类芽孢杆菌NP1、木聚糖酶PtXyn1及其编码基因和应用 | |
CN107058168B (zh) | 一种巨大芽孢杆菌及其产普鲁兰酶的方法与产品 | |
CN109554355A (zh) | 具有纤维素降解增强活性的多肽及其应用 | |
CN112501049B (zh) | 产转糖基活性β-半乳糖苷酶的开菲尔乳杆菌及制备的β-半乳糖苷酶生产低聚半乳糖的方法 | |
CN114806900A (zh) | 一种可以分泌纤维膨胀蛋白的工程菌株、构建方法及应用 | |
CN117106833B (zh) | 一种利用酶解协同压热处理制备的高益生性莲子抗性淀粉及其制备方法和应用 | |
CN112029751B (zh) | 一种嗜热真菌甘露聚糖酶的生产方法及其应用 | |
CN102816750B (zh) | 一种来源于嗜酸耐热菌的第113家族的新β-甘露聚糖酶、基因和及其应用 | |
CN114457059B (zh) | 一种含木聚糖酶的酶制剂及其在用于生产低聚木糖中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20933055 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20933055 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 10/05/2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20933055 Country of ref document: EP Kind code of ref document: A1 |